High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan

被引:69
作者
Lin, H
Ma, YY
Moh, JS
Ou, YC
Shen, SY
ChangChien, CC
机构
[1] Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan
[2] Wu Kun Che Gynecol & Pediat Hosp, Kaohsiung, Taiwan
[3] YingMing Res Lab, Kaohsiung, Taiwan
[4] Fortune Inst Technol, Kaohsiung, Taiwan
[5] Chang Gung Univ, Kaohsiung, Taiwan
关键词
human papillomavirus; prevalence;
D O I
10.1016/j.ygyno.2005.09.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. We attempted to determine the prevalence of genital human papillomavirus (HPV) infection in women attending gynecologic practitioners in South Taiwan. Methods. The population included 4383 women aged 16-78 seeking HPV testing at primary gynecologic practitioners regardless of their cervical cytology results. HPV DNA was identified from cervical swabs using semi-nested polymerase chain reaction with MY11, MY09/HMB01, and MY11/bioGP6+ primers. Genotyping for high-risk HPV (HR-HPV) was done separately by a HR-HPV chip, which contained 13 type-specific oligonucleotides on a nylon membrane. Results. The overall HPV prevalence was 19.3% (849/4383), 11.1% (488/4383) were confirmed as HR-HPV positive. Among the women with HR-HPV infection, HPV-16 was the most prevalent type (22.1%; 108/488), followed by HPV-52 (21.3%; 104/488), and HPV-58 (19.9%; 97/ 488). Multiple infections were detected in 73 women (15.0%; 73/488). For women with age 30 or younger, the overall HPV and HR-HPV prevalence were 32.0% and 20.7%, respectively, which were significantly higher than those of women age older than 30 (17.2% and 9.5%, P < 0.001). More multiple infections (22.1% vs. 12.4%) were also found in women with age 30 or younger (P = 0.021). However, the relative contribution of types to the overall HR-HPV positive among different age groups remains the same. Conclusions. Our results showed an HPV prevalence that is similar compared with worldwide levels. HPV prevalence and multiple infections rate were decreasing across the age groups. Unlike most previous studies, the relative high prevalence of HPV 52 and 58 among South Taiwan women has important implications in vaccine prophylaxis. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:40 / 45
页数:6
相关论文
共 47 条
[1]   Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece [J].
Agorastos, T ;
Dinas, K ;
Lloveras, B ;
Bosch, FX ;
Kornegay, JR ;
Bontis, JN ;
de Sanjose, S .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2004, 13 (02) :145-147
[2]   Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method [J].
An, HJ ;
Cho, NH ;
Lee, SY ;
Kim, IH ;
Lee, C ;
Kim, SJ ;
Mun, MS ;
Kim, SH ;
Jeong, JK .
CANCER, 2003, 97 (07) :1672-1680
[3]   GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE UNIVERSITY-STUDENTS AS DETERMINED BY A PCR-BASED METHOD [J].
BAUER, HM ;
TING, Y ;
GREER, CE ;
CHAMBERS, JC ;
TASHIRO, CJ ;
CHIMERA, J ;
REINGOLD, A ;
MANOS, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04) :472-477
[4]   Human papillomavirus infection of the cervix uteri in women attending a Health Examination Center of the French social security [J].
Beby-Defaux, A ;
Bourgoin, A ;
Ragot, S ;
Battandier, D ;
Lemasson, JM ;
Renaud, O ;
Bouguermouh, S ;
Agius, G .
JOURNAL OF MEDICAL VIROLOGY, 2004, 73 (02) :262-268
[5]   IDENTIFICATION AND ASSESSMENT OF KNOWN AND NOVEL HUMAN PAPILLOMAVIRUSES BY POLYMERASE CHAIN-REACTION AMPLIFICATION, RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS, NUCLEOTIDE-SEQUENCE, AND PHYLOGENETIC ALGORITHMS [J].
BERNARD, HU ;
CHAN, SY ;
MANOS, MM ;
ONG, CK ;
VILLA, LL ;
DELIUS, H ;
PEYTON, CL ;
BAUER, HM ;
WHEELER, CM .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1077-1085
[6]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[7]   Human papillomavirus vaccines [J].
Breitburd, F ;
Coursaget, P .
SEMINARS IN CANCER BIOLOGY, 1999, 9 (06) :431-445
[8]   Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors [J].
Burk, RD ;
Kelly, P ;
Feldman, J ;
Bromberg, J ;
Vermund, SH ;
Dehovitz, JA ;
Landesman, SH .
SEXUALLY TRANSMITTED DISEASES, 1996, 23 (04) :333-341
[9]   A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica [J].
Castle, PE ;
Schiffman, M ;
Herrero, R ;
Hildesheim, A ;
Rodriguez, AC ;
Bratti, MC ;
Sherman, ME ;
Wacholder, S ;
Tarone, R ;
Burk, RD .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (11) :1808-1816
[10]  
Chan PKS, 1999, J MED VIROL, V59, P232, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt